市场调查报告书
商品编码
1182111
全球肾上腺皮质类固醇市场规模研究与预测:按产品、给药途径、应用和地区分析,2022-2029Global Corticosteroids Market Size study & Forecast, by Product, Route of Administration, Application and Regional Analysis, 2022-2029 |
肾上腺皮质产生的一种类固醇激素,用于治疗多种疾病,如肾脏病、自身免疫性疾病、胃肠病、皮肤病、脑水肿等。
这些类固醇还用于替代疗法和器官移植。 肾上腺皮质激素市场因慢性病和感染增加、治疗药物应用增加等因素而不断扩大。 预计在整个预测期内,製药行业正在进行的研究和开发将开闢新的市场潜力。
根据联合国发布的2020年报告,预计到2025年,目前的72亿人口将增至82亿。 因此,到 2020 年底,全球慢性病负担预计将上升至 57%。 根据美国疾病控制和预防中心 2020 年的报告,大约有 2500 万美国人患有哮喘。 这大约是三分之一的美国人、8% 的成年人和 7% 的儿童。 哮喘影响着超过 2000 万 18 岁及以上的美国人。 然而,与长期使用皮质类固醇相关的风险因素将阻碍整个 2022-2029 年预测期内的市场增长。
研究全球皮质类固醇市场的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于与生活方式相关的疾病发病率上升、经济发展和医疗保健成本上升,北美在收入方面占据主导地位。 然而,由于技术先进产品的高度采用,预计亚太地区将成为增长最快的地区。
这项研究的目的是揭示近年来不同细分市场和国家/地区的市场规模,并预测未来几年的价值。 本报告旨在捕捉被调查国家行业的定性和定量方面的情况。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还包含供利益相关者投资的潜在微观市场机会,以及对主要参与者的竞争格局和产品供应的深入分析。
Global Corticosteroids Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.3% over the forecast period 2022-2029. Corticosteroids are a group of steroidal hormones that are generated in the adrenal cortex and are used to treat a variety of diseases, including kidney disease, autoimmune illness, GIT disease, skin disease, cerebral edema, and others. These steroids are also used in replacement treatment and organ transplantation. The Corticosteroids market is expanding because of factors such increase in the prevalence of chronic & infectious diseases and a rise in therapeutical product application. Continuing R&D in the pharmaceutical sector is predicted to open up new market possibilities throughout the forecast period.
According to the United Nations report 2020, the anticipated human population would rise from 7.2 billion now to 8.2 billion by 2025. By the end of 2020, this causes the worldwide burden of chronic illnesses to increase to 57%. About 25 million Americans have asthma, according to the Centers for Disease Control and Prevention's 2020 report. This equates to around 1 in 13 Americans, which includes 8% of adults and 7% of children. Asthma affects over 20 million American individuals who are 18 years of age and older. However, risk factors associated with Corticosteroids on Prolonged use stifle market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Corticosteroids Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the increasing incidence of lifestyle-related diseases and developed economy, increasing health care expenditure. However, Asia Pacific is expected to be the fastest growing region due to the high adoption of technologically advanced products.
Major market players included in this report are:
Johnson & Johnson Services, Inc.
Pfizer Inc.
Sumitomo Corporation
GlaxoSmithKline plc
Novartis AG
Bayer AG Pharmaceutical
Sanofi S.A.
AstraZeneca plc
Merck & Co., Inc.
Cipla Inc.
Recent Developments in the Market:
Global Corticosteroids Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Route of Administration, Application, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.
The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Glucocorticoids
Mineralocorticoids
By Route of Administration:
Topical steroids
Inhaled steroids
Oral forms
Systemic forms
Others
By Application:
Rheumatology indications
Skin allergies
Endocrinology
Gastroenterology
Acute respiratory diseases
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable